Seres Therapeutics Q3 EPS $(1.63) Misses $(1.00) Estimate, Sales $593.000K Miss $6.350M Estimate
Benzinga Newsdesk 6 hours ago
NewsEarningsEarnings Misses
Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(1.63) per share which missed the analyst consensus estimate of $(1.00) by 63 percent. This is a 273.4 percent decrease over earnings of $0.94 per share
Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(1.63) per share which missed the analyst consensus estimate of $(1.00) by 63 percent. This is a 273.4 percent decrease over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $593.000 thousand which missed the analyst consensus estimate of $6.350 million by 90.66 percent. This is a 68.95 percent increase over sales of $351.000 thousand the same period last year.